Medtronic announces layoffs of about 1,000 from various divisions as the company's cardiac rhythm management and spinal products see continued declines, but the slump may be slowing.

Medtronic's (NYSE:MDT) bellwether 4th quarter and full-year earnings noted a continued decline in U.S. cardiac rhythm management and spinal products, but the slump may be slowing, the company said.
Concerns that the medical device tax will push companies to lay off workers and move operations...
The FDA clears OrthoSensor's Verasense device, designed to help surgeons fit knee replacement...
ArtVentive Medical Group wins CE Mark approval in the European Union for its EOS peripheral vascular...
The FDA hits Endologix's catheter introducer device recall with Class I status, its most serious...
A blogger's speculation that pSivida might be in line for a buyout bid sends the ophthalmology...